Compile Data Set for Download or QSAR
maximum 50k data
Found 70 Enz. Inhib. hit(s) with all data for entry = 9980
TargetSentrin-specific protease/Small ubiquitin-related modifier 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US11041859, Code SPI-01 | US9791447, Comp...)
Affinity DataIC50:  1.10E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US11041859, Code SPI-01 | US9791447, Comp...)
Affinity DataIC50:  1.42E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  1.60E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  1.86E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US11041859, Code SPI-01 | US9791447, Comp...)
Affinity DataIC50:  1.88E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103832(SPI-07 | US11041859, Code SPI-07)
Affinity DataIC50:  1.90E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103834(SPI-09 | US11041859, Code SPI-09 | US9791447, Comp...)
Affinity DataIC50:  1.90E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103835(SPI-10 | US11041859, Code SPI-10 | US9791447, Comp...)
Affinity DataIC50:  2.00E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US11041859, Code SPI-02 | US9791447, Comp...)
Affinity DataIC50:  2.00E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US11041859, Code SPI-02 | US9791447, Comp...)
Affinity DataIC50:  2.08E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US11041859, Code SPI-02 | US9791447, Comp...)
Affinity DataIC50:  2.10E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  2.15E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  2.30E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  2.32E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  2.40E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  2.40E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103835(SPI-10 | US11041859, Code SPI-10 | US9791447, Comp...)
Affinity DataIC50:  2.40E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103835(SPI-10 | US11041859, Code SPI-10 | US9791447, Comp...)
Affinity DataIC50:  2.50E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US11041859, Code SPI-02 | US9791447, Comp...)
Affinity DataIC50:  2.70E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US11041859, Code SPI-02 | US9791447, Comp...)
Affinity DataIC50:  2.70E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103833(SPI-08 | US11041859, Code SPI-08 | US9791447, Comp...)
Affinity DataIC50:  2.80E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US11041859, Code SPI-01 | US9791447, Comp...)
Affinity DataIC50:  2.90E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  3.00E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  3.40E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103827(SPI-02 | US11041859, Code SPI-02 | US9791447, Comp...)
Affinity DataIC50:  3.42E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US11041859, Code SPI-01 | US9791447, Comp...)
Affinity DataIC50:  3.50E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US11041859, Code SPI-06 | US9791447, Co...)
Affinity DataIC50:  3.62E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US11041859, Code SPI-06 | US9791447, Co...)
Affinity DataIC50:  3.70E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  3.80E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US11041859, Code SPI-06 | US9791447, Co...)
Affinity DataIC50:  3.90E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103833(SPI-08 | US11041859, Code SPI-08 | US9791447, Comp...)
Affinity DataIC50:  4.10E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US11041859, Code SPI-06 | US9791447, Co...)
Affinity DataIC50:  4.32E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US11041859, Code SPI-05 | US9791447, Comp...)
Affinity DataIC50:  4.60E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US11041859, Code SPI-05 | US9791447, Comp...)
Affinity DataIC50:  4.60E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US11041859, Code SPI-06 | US9791447, Co...)
Affinity DataIC50:  4.70E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSentrin-specific protease 7(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  4.80E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  5.17E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103826(SPI-01 | US11041859, Code SPI-01 | US9791447, Comp...)
Affinity DataIC50:  5.90E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103834(SPI-09 | US11041859, Code SPI-09 | US9791447, Comp...)
Affinity DataIC50:  6.80E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US11041859, Code SPI-05 | US9791447, Comp...)
Affinity DataIC50:  7.50E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US11041859, Code SPI-05 | US9791447, Comp...)
Affinity DataIC50:  8.50E+3nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM348888(NSC70551 | US11041859, Code SPI-06 | US9791447, Co...)
Affinity DataIC50:  1.07E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103835(SPI-10 | US11041859, Code SPI-10 | US9791447, Comp...)
Affinity DataIC50:  1.11E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103829(SPI-04 | US11041859, Code SPI-04 | US9791447, Comp...)
Affinity DataIC50:  1.12E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US11041859, Code SPI-05 | US9791447, Comp...)
Affinity DataIC50:  1.33E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103833(SPI-08 | US11041859, Code SPI-08 | US9791447, Comp...)
Affinity DataIC50:  1.72E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSmall ubiquitin-related modifier 1/2(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103832(SPI-07 | US11041859, Code SPI-07)
Affinity DataIC50:  1.75E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 2/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103830(SPI-05 | US11041859, Code SPI-05 | US9791447, Comp...)
Affinity DataIC50:  1.97E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease/Small ubiquitin-related modifier 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103828(SPI-03 | US11041859, Code SPI-03)
Affinity DataIC50:  2.03E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSentrin-specific protease 1(Homo sapiens (Human))
City Of Hope

US Patent
LigandPNGBDBM103833(SPI-08 | US11041859, Code SPI-08 | US9791447, Comp...)
Affinity DataIC50:  2.22E+4nMAssay Description:The inhibitors confer the non-competitive inhibitory mechanism, as shown by nuclear magnetic resonance (NMR) and quantitative enzyme kinetic analysis...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 70 total ) | Next | Last >>
Jump to: